Phosphorus P-32: Side Effects, Uses & Monitoring
P32 sodium phosphate is indicated for the treatment of polycythemia vera and is effective for the treatment of chronic myelocytic leukemia and chronic lymphocytic leukemia.
- Data source
- FDA labeling via NIH DailyMed (label 735f92e3…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
P32 sodium phosphate is indicated for the treatment of polycythemia vera and is effective for the treatment of chronic myelocytic leukemia and chronic lymphocytic leukemia. It may also be used in the palliative treatment of selected patients with multiple areas of skeletal metastases
Conditions associated with Phosphorus P-32 in labeling
Frequently Asked Questions
What is Phosphorus P-32 used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Phosphorus P-32?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Phosphorus P-32 require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Phosphorus P-32.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.